P1156: MAGNIFY PHASE 3B STUDY OF LENALIDOMIDE + RITUXIMAB (R2) FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: COMPLETE INDUCTION PHASE ANALYSIS
P1156:MAGNIFY 3B期研究,评估来那度胺+利妥昔单抗(R2)治疗复发/难治性惰性非霍奇金淋巴瘤的疗效,随后进行维持治疗:完整的诱导期分析
期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S363493
Alter, Peter; Orszag, Jan; Wouters, Emiel F M; Vogelmeier, Claus F; Jörres, Rudolf A; Lansigan, F; Andorsky, D J; Coleman, M; Yacoub, A; Melear, J M; Fanning, S R; Kolibaba, K S; Reynolds, C; Nowakowski, G S; Gharibo, M; Ahn, J R; Li, J; Rummel, M J; Sharman, J P